Edwards Lifesciences Corporation
Edwards Lifesciences Corporation (EW) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · EW · as of Sep 30, 2025
Ownership Breakdown
1,316
Institutional Holders
▲ 6 vs Q2
$38.18B
Total Inst. Value
▼ $1.05B vs Q2
575.80M
Shares Outstanding
freeFloat 98.73%
491.30M
13F Shares Held
▼ 11.17M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
EW largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC orthopedic, prosthetic & surgical appliances & supplies | 70.36M | 11.99% | 11.99% | $5.47T | Nov 7, 2025 | ▲ 365.6K |
BLACKROCK, INC. orthopedic, prosthetic & surgical appliances & supplies | 54.29M | 9.25% | 9.25% | $4.22T | Nov 12, 2025 | ▼ 1.35M |
STATE STREET CORP orthopedic, prosthetic & surgical appliances & supplies | 25.62M | 4.36% | 4.36% | $1.99T | Nov 14, 2025 | ▼ 14.7K |
JPMORGAN CHASE & CO orthopedic, prosthetic & surgical appliances & supplies | 25.06M | 4.27% | 4.27% | $1.95T | Nov 26, 2025 | ▼ 1.71M |
WELLINGTON MANAGEMENT GROUP LLP orthopedic, prosthetic & surgical appliances & supplies | 20.80M | 3.54% | 3.54% | $1.62T | Nov 14, 2025 | ▲ 977.9K |
BANK OF NEW YORK MELLON CORP orthopedic, prosthetic & surgical appliances & supplies | 19.01M | 3.24% | 3.24% | $1.48T | Nov 3, 2025 | ▲ 1.42M |
FMR LLC orthopedic, prosthetic & surgical appliances & supplies | 14.58M | 2.48% | 2.48% | $1.13T | Nov 13, 2025 | ▲ 12.05M |
JENNISON ASSOCIATES LLC orthopedic, prosthetic & surgical appliances & supplies | 13.96M | 2.38% | 2.38% | $1.09T | Oct 30, 2025 | ▲ 2.29M |
GEODE CAPITAL MANAGEMENT, LLC orthopedic, prosthetic & surgical appliances & supplies | 12.84M | 2.19% | 2.19% | $993.49B | Nov 12, 2025 | ▲ 114.7K |
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN orthopedic, prosthetic & surgical appliances & supplies | 9.24M | 1.57% | 1.57% | $718.61B | Nov 14, 2025 | ▲ 110.8K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
24
Increased
+27.70M shares2
New Positions
first time holders22
Decreased
−25.60M shares0
Sold Out
fully exitedNet shares change (top 50)
+2.10M
+27.70M / −25.60M
Net new holders
+4
2 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
EW insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
46
Buy transactions
57
Sell transactions
0.81
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Dahl Andrew M. SVP, Corporate Controller | May 29, 2026 | Sale | 567.527 | $86.08 | $48.9K | 15.3K | Form 4 ↗ |
BOBO DONALD E JR CVP,Strategy/Corp Development | May 27, 2026 | Sale | 23,145 | $86.42 | $2.00M | 98.6K | Form 4 ↗ |
Chopra Daveen CVP, TMTT & Surgical | May 22, 2026 | Sale | 1,500 | $84.60 | $126.9K | 44.3K | Form 4 ↗ |
Lippis Daniel J. CVP, TAVR | May 18, 2026 | Sale | 620 | $81.14 | $50.3K | 40.4K | Form 4 ↗ |
BOBO DONALD E JR CVP,Strategy/Corp Development | May 15, 2026 | Sale | 8,000 | $81.82 | $654.6K | 31.0K | Form 4 ↗ |
BOBO DONALD E JR CVP,Strategy/Corp Development | May 15, 2026 | Sale | 9,968 | $82.07 | $818.1K | 22.8K | Form 4 ↗ |
Zovighian Bernard J CEO | May 11, 2026 | Tax Withhold | 26,198 | $79.96 | $2.09M | 125.8K | Form 4 ↗ |
Zovighian Bernard J CEO | May 12, 2026 | Gift | 26,640 | — | — | 99.2K | Form 4 ↗ |
Zovighian Bernard J CEO | May 12, 2026 | Gift | 26,640 | — | — | 48.4K | Form 4 ↗ |
Zovighian Bernard J CEO | May 12, 2026 | Sale | 845 | $78.40 | $66.3K | 47.5K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Edwards Lifesciences Corporation (EW) is primarily owned by institutional investors, who hold approximately 85.3% of total shares outstanding. Company insiders own approximately 1.27%, while retail and public investors account for the remaining 13.41%.
The largest institutional shareholder of Edwards Lifesciences Corporation is VANGUARD GROUP INC, holding approximately 70.36 million shares — equal to 11.99% of outstanding shares — as of September 30, 2025.
A total of 1,316 institutional investors currently hold EW stock, with a combined institutional value of approximately $38.18 billion as of the most recent 13F filing period.
Frequently asked questions
EW ownershipEdwards Lifesciences Corporation (EW) is primarily owned by institutional investors, who hold approximately 85.3% of shares. The largest shareholder is VANGUARD GROUP INC with a 11.99% stake. Company insiders hold 1.27%. Data sourced from SEC Form 13F as of September 30, 2025.